Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
03/06/2026 07:02
BRIEF-Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln June 3 (Reuters) - Nanobiotix SA NANOB.PA:
SAID ON TUESDAY IT COMPLETED A FOLLOW-ON OFFERING FOR €86.1 MILLION IN MAY 2026
CASH AND CASH EQUIVALENTS AS OF MARCH 31 €42.1 MILLION
NET PROCEEDS FROM RECENT FOLLOW-ON OFFERING AND CURRENT CASH POSITION EXPECTED TO FUND OPERATIONS INTO 2029
Source text: ID:nNDL2nftrJ
Further company coverage: NANOB.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nanobiotix SA
See all newsBrief: Nanobiotix S.A. H1 Net Income EUR -34.3 Million
France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gain
Brief: Nanobiotix Reports Encouraging Full Phase 1 Results For Lung Cancer Drug JNJ-1900
Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
Brief: NANOBIOTIX Announces Closing Of Global Offering